These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22004289)

  • 1. Progression of normal tension glaucoma in Kearns-Sayre syndrome over 10 years.
    Zarnowski T; Kosior-Jarecka E
    Clin Exp Ophthalmol; 2012 Mar; 40(2):218-20. PubMed ID: 22004289
    [No Abstract]   [Full Text] [Related]  

  • 2. Target intraocular pressure for stability of visual field loss progression in normal-tension glaucoma.
    Aoyama A; Ishida K; Sawada A; Yamamoto T
    Jpn J Ophthalmol; 2010 Mar; 54(2):117-23. PubMed ID: 20401559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Single-Digit IOP Targets on Decreasing Global and Localized Visual Field Progression After Filtration Surgery in Eyes With Progressive Normal-Tension Glaucoma.
    Iverson SM; Schultz SK; Shi W; Feuer WJ; Greenfield DS
    J Glaucoma; 2016 May; 25(5):408-14. PubMed ID: 25719235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
    Brüggemann A; Despouy JT; Wegent A; Müller M
    J Glaucoma; 2013 Sep; 22(7):577-83. PubMed ID: 23632395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
    Suominen S; Harju M; Kurvinen L; Vesti E
    Acta Ophthalmol; 2014 Nov; 92(7):701-6. PubMed ID: 24373326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of corneal biomechanical properties in patients with progressive normal-tension glaucoma.
    Park JH; Jun RM; Choi KR
    Br J Ophthalmol; 2015 Jun; 99(6):746-51. PubMed ID: 25555704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preperimetric normal tension glaucoma study: long-term clinical course and effect of therapeutic lowering of intraocular pressure.
    Jeong JH; Park KH; Jeoung JW; Kim DM
    Acta Ophthalmol; 2014 May; 92(3):e185-93. PubMed ID: 24456145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of visual field defects in eyes with different optic disc appearances in patients with normal tension glaucoma.
    Nakazawa T; Shimura M; Ryu M; Himori N; Nitta F; Omodaka K; Doi H; Yasui T; Fuse N; Nishida K
    J Glaucoma; 2012 Aug; 21(6):426-30. PubMed ID: 22314251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy.
    Law SK; Nguyen AM; Coleman AL; Caprioli J
    Arch Ophthalmol; 2007 Aug; 125(8):1044-50. PubMed ID: 17698750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabeculectomy for normal tension glaucoma: outcomes using the Moorfields Safer Surgery technique.
    Jayaram H; Strouthidis NG; Kamal DS
    Br J Ophthalmol; 2016 Mar; 100(3):332-8. PubMed ID: 26198279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
    De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
    Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure.
    Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
    Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
    Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of repeat trabeculectomies.
    Olali C; Rotchford AP; King AJ
    Clin Exp Ophthalmol; 2011; 39(7):658-64. PubMed ID: 22452683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction.
    Park HY; Park SH; Park CK
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2557-63. PubMed ID: 24692126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal-tension glaucoma: managing a case of mistaken identity.
    Samaha D
    Clin Exp Optom; 2019 Sep; 102(5):523-527. PubMed ID: 30652387
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study.
    Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH
    Acta Ophthalmol; 2013 Jun; 91(4):e270-5. PubMed ID: 23406253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between 24-hour mean ocular perfusion pressure fluctuation and rate of paracentral visual field progression in normal-tension glaucoma.
    Choi J; Lee JR; Lee Y; Lee KS; Na JH; Han S; Kook MS
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6150-7. PubMed ID: 23963166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency doubling technology for earlier detection of functional damage in standard automated perimetry-normal hemifield in glaucoma with low-to-normal pressure.
    Nakagawa S; Murata H; Saito H; Nakahara H; Mataki N; Tomidokoro A; Iwase A; Araie M
    J Glaucoma; 2012 Jan; 21(1):22-6. PubMed ID: 21543995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low diastolic blood pressure is associated with the progression of normal-tension glaucoma.
    Okumura Y; Yuki K; Tsubota K
    Ophthalmologica; 2012; 228(1):36-41. PubMed ID: 22377835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.